A revitalised Oxford BioDynamics have been laying the foundations to strike a partnership that would take their market leading precision medical tests out into the global marketplace - a potentially transformational moment for the company.

Harena is London's latest stock market entrant offering early stage exposure to a hot commodity, namely Rare Earths, particularly the likes of critical magnet metals Neodymium (Nd), Praseodymium (Pr), Dysprosium (Dy) and Terbium (Tb). Here are 5 Reasons to watch it!

A lot has happened since my last article on EnergyPathways PLC (Ticker: EPP) and if the past few months are anything to go by, it looks like the second half of 2025 will be action-packed.

Pantheon's shares have taken a battering this week on news that the Megrez-1 TS1 Target was predominantly water bearing. However, the company believe that data gathered, increases confidence in the productivity and hydrocarbon potential of the intervals higher with 5 futher intervals to test.

In little over a month, Oxford BioDynamics have inked two deals relating to the distribution and sales of its market leading Prostate Cancer PSE test. Does this mark the start of a turnaround for the company?

Blencowe Resources are entering a critical point in the valuation curve as they close out the last stages of the Orom-Cross DFS that will outline a 5 Phase approach to Blencowe becoming a major player in the critical minerals, graphite space.